Добірка наукової літератури з теми "Pharmaceutical producers"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Pharmaceutical producers".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Pharmaceutical producers"
Sridharan, Perumal. "Multinational Diversification and Pharmaceutical Units Performance: Evidence from Indian Firms." Ushus - Journal of Business Management 12, no. 3 (July 7, 2013): 77–87. http://dx.doi.org/10.12725/ujbm.24.5.
Повний текст джерелаMance, Davor, Nenad Vretenar, and Antonija Gudelj. "Mergers and Acquisitions as a Consequence of Declining Innovation Productivity in Pharmaceuticals: Evidence from Croatia." Mednarodno inovativno poslovanje = Journal of Innovative Business and Management 12, no. 1 (June 30, 2020): 1–8. http://dx.doi.org/10.32015/jibm/2020-12-1-1.
Повний текст джерелаIyengar, Renganthan. "PHARMACEUTICAL PRICING POLICY AND CONTROL– INDIAN PERSPECTIVE." Asian Journal of Pharmaceutical and Clinical Research 9, no. 6 (November 1, 2016): 305. http://dx.doi.org/10.22159/ajpcr.2016.v9i6.14461.
Повний текст джерелаDerenska, Yana. "Approaches to project portfolio formation by pharmaceutical products producers." Economic Annals-ХХI 176, no. 3-4 (August 20, 2019): 99–108. http://dx.doi.org/10.21003/ea.v176-10.
Повний текст джерелаMamedyarov, Z. A. "Pharmaceutical Industry Development in the Midst of Crisis: Global Trends." MIR (Modernization. Innovation. Research) 11, no. 4 (December 28, 2020): 398–408. http://dx.doi.org/10.18184/2079-4665.2020.11.4.398-408.
Повний текст джерелаCurti, Andrea M. "The WTO Dispute Settlement Understanding: An Unlikely Weapon in the Fight Against AIDS." American Journal of Law & Medicine 27, no. 4 (2001): 469–85. http://dx.doi.org/10.1017/s0098858800008224.
Повний текст джерелаZhou, Lilong, Chen Ma, Jonathan Horlyck, Runjing Liu, and Jimmy Yun. "Development of Pharmaceutical VOCs Elimination by Catalytic Processes in China." Catalysts 10, no. 6 (June 13, 2020): 668. http://dx.doi.org/10.3390/catal10060668.
Повний текст джерелаHondius, Ewoud H. "A Dutch DES case: Pharmaceutical Producers Jointly and Severally Liable." European Review of Private Law 2, Issue 3/4 (December 1, 1994): 409–13. http://dx.doi.org/10.54648/erpl1994044.
Повний текст джерелаKokkini, Maria, Cristina González Heredia, Daniel Oves-Costales, Mercedes de la Cruz, Pilar Sánchez, Jesús Martín, Francisca Vicente, Olga Genilloud, and Fernando Reyes. "Exploring Micromonospora as Phocoenamicins Producers." Marine Drugs 20, no. 12 (December 7, 2022): 769. http://dx.doi.org/10.3390/md20120769.
Повний текст джерелаSadek, Md Abu Zafor. "Pharmaceutical Plastic Packaging Market in Bangladesh: A Study on Demand-Supply Scenario and Strategic Imperatives for Local Enterprises." International Journal of Business and Management 12, no. 3 (February 21, 2017): 232. http://dx.doi.org/10.5539/ijbm.v12n3p232.
Повний текст джерелаДисертації з теми "Pharmaceutical producers"
Alev, Isil. "Operational perspectives on extended producer responsibility for durable and consumable products." Diss., Georgia Institute of Technology, 2015. http://hdl.handle.net/1853/54382.
Повний текст джерелаOliva, Viera Ivette Lorena. "Factores que determinaron el incremento de las importaciones de los productos farmacéuticos chinos en el Perú, entre el 2013 al 2017." Bachelor's thesis, Universidad Peruana de Ciencias Aplicadas (UPC), 2019. http://hdl.handle.net/10757/628116.
Повний текст джерелаThis research aims to determine those factors that generated the increase in imports of Chinese pharmaceutical products in Peru, between 2013 and 2017. In principle, secondary sources of the pharmaceutical industry and application theories were analyzed to better understand the industry and to know the most relevant factors that are driving the increase in these Chinese imports, especially for having a direct impact on health and health. people's well-being According to the exhaustive research in the theoretical framework, it was determined that capital and labor, diversification, logistics costs, policy regime and industrial capacity are determining factors that contribute to the increase in product imports. Chinese pharmacists in Peru. Meanwhile, the applied work methodology corresponds to a qualitative - descriptive study, with a non-experimental design and that uses the in-depth interview as a research instrument, the result of which showed that four of the five factors are considered determinants in relation to Our subject of study. That is, the diversification factor was not considered decisive for the present subject of study. Due to the research, it is recommended that the national and private pharmaceutical industry make better business practices regarding the use of these factors so that they can not only emulate what China has done, but also increase their competitiveness in the Peruvian market towards an industry most strengthened pharmaceutical.
Tesis
Adolfsson, Per. "Export of Pharmaceutical Products : An analysis of which factors that affects Sweden’s export of pharmaceutical products." Thesis, Jönköping University, JIBS, Economics, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-951.
Повний текст джерелаThe pharmaceutical industry is one of Sweden’s most important export industries with 6% of total exports. The purpose of this thesis is to analyse which factors affect Sweden’s ex-port of pharmaceutical products. Further, the different pharmaceutical products group Sweden exports will be identified. The modern trade theory, the monopolistic competition model, the product life cycle theory and the gravity equation are used to explain and to un-derstand the problem at hand.
To analyse the problem, data of Swedish export of pharmaceutical products from 1997 to 2003 was used to the 176 destination countries Sweden exported to during the time period. The following factors were used as independent variables; distance, Gross Domestic Prod-uct (GDP) /capita, Area, Population, dummy variable for EU-membership, dummy vari-able for English or Scandinavian speaking countries, dummy variable for bordering to Sweden, dummy variable for same religion as Sweden and a dummy variable for countries that are not land-locked.
The findings coincide with previous studies in the manner that distance and GDP/capita have a major impact on the sales abroad of pharmaceutical products. Also, countries with a larger population are importing more than countries with a smaller population. However, the strong affinities between the exporter and the importing countries found in previous studies were not found in the export of pharmaceutical products. Further, Sweden exports most of the product group that includes medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses.
Läkemedelsindustrin är en av Sveriges viktigaste exportindustrier med 6 % av den totala exporten. Syftet med denna uppsats är därför att analysera vilka faktorer som påverkar dess export. Vidare, de olika exportgrupperna av läkemedel som Sverige exporterar kommer att identifieras. Den moderna handelsteorin, monopolistisk konkurrens, produktcykelteorin och gravitationsmodellen används för att förklara och förstå det uppstådda problemet.
För att analysera problemet så används Sveriges export av läkemedel från 1997 till 2003 för alla 176 destinationer. Följande faktorer används som oberoende variabler; distansen, BNP/capita, arean, folkmängd, dummy variabel för EU-medlemskap, dummy variabel för engelsk- eller skandinaviskspråkiga länder, dummy variabel för gränsande länder till Sverige, dummy variabel för länder som har samma religion som Sverige, samt en dummy variabel för länder som angränsar till vatten.
Resultatet överensstämmer med tidigare forskning att avståndet och BNP/capita har ett stort inflytande av exporten av läkemedel. Likaså länder med ett stort invånarantal importe-rar mer än länder med ett mindre invånarantal. Däremot, det starka släktskapet mellan ex-portören och de importerande länderna som funnits i tidigare studier observerades inte i exporten av läkemedel. Vidare, Sverige exporterar mest av produktgruppen som innehåller medikamenter bestående av blandade eller oblandade produkter för terapeutiskt eller profy-laktiskt bruk.
Komak, Wagma, Jeremy Smart, and Jennifer White. "Quality Assessment of Internet Pharmaceutical Products." The University of Arizona, 2007. http://hdl.handle.net/10150/624403.
Повний текст джерелаObjectives: The purpose of this study is to assess the quality of study medications obtained without a prescription through international websites. Methods: Samples of levothyroxine, warfarin, and sildenafil were obtained through various websites and compared to U.S. standards. Each sample was physically evaluated for weight, color, shape, and external tablet markings. High performance liquid chromatography (HPLC) was performed to quantify the amount of active ingredient. Results: When physically inspected, only 3 of the 9 lots met FDA labeling requirements. Three of 60 (20 tablets from 3 lots) of the individual levothyroxine tablets were out of the USP acceptable range (90% - 110%). For warfarin, 16 of the 60 samples (20 samples from 3 lots) of the individual tablets were out of the USP acceptable range (95% - 105%). When averaged, each of the lots for both levothyroxine and warfarin were within their USP acceptable ranges. As sildenafil is not available as generic in the U.S., there is no USP standard acceptable range for comparison. All of the sildenafil samples fell within 90%- 105% of Viagra® tablets obtained from a local pharmacy. Conclusions: While there were a few samples outside of the U.S. acceptable range, the majority of samples analyzed for active ingredient were within the range published in the USP. While the outcomes of this study presented interesting findings, further evaluation in larger studies is needed to properly assess the quality of foreign medications purchased over the internet.
Sadeghnejad, G. R. "Thermoodynamic properties and characterisation of pharmaceutical materials." Thesis, University of Bradford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.371530.
Повний текст джерелаÖstlund, Martin. "AssistancePlus : 3D-mediated Advice-giving on Pharmaceutical Products." Licentiate thesis, Linköping University, Linköping University, NLPLAB - Natural Language Processing Laboratory, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-12159.
Повний текст джерелаIn the use of medication and pharmaceutical products, non‐compliance is a major problem. One thing we can do something about is making sure consumers have the information they need. This thesis investigates how remote communication technology can be used to improve the availability for expressive advice‐giving services. Special attention is given to the balancing of expressiveness and availability. A solution is presented that uses 3D visualisation in combination with audio and video communication to convey advice on complex pharmaceutical products. The solution is tested and evaluated in two user studies. The first study is broad and explorative, the second more focused and evaluative. The solution was well received by participating subjects. They welcomed the sense of personal contact that seeing the communicating party over video link produced and appreciated the expressive power and pedagogical value of the 3D materials. Herbert Clark’s theory of use of language is suggested as a framework for the analysis of the dynamics of the relationship between
consumer and advisor.
Report code: LiU-Tek-Lic-2008:31.
Östlund, Martin. "AssistancePlus : 3D-mediated advice-giving on pharmaceutical products /." Linköping : Department of Computer and Information Science, Linköpings universitet, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-12159.
Повний текст джерелаBara, Carlos Roberto Francisco. "Does humor work in advertising of pharmaceutical products?" reponame:Repositório Institucional do FGV, 2010. http://hdl.handle.net/10438/8196.
Повний текст джерелаApproved for entry into archive by Vera Lúcia Mourão(vera.mourao@fgv.br) on 2011-05-25T16:55:56Z (GMT) No. of bitstreams: 1 61090100017.pdf: 1173276 bytes, checksum: cda7eb208e82169a3eb90adf64163258 (MD5)
Approved for entry into archive by Vera Lúcia Mourão(vera.mourao@fgv.br) on 2011-05-25T16:58:29Z (GMT) No. of bitstreams: 1 61090100017.pdf: 1173276 bytes, checksum: cda7eb208e82169a3eb90adf64163258 (MD5)
Made available in DSpace on 2011-05-25T17:23:04Z (GMT). No. of bitstreams: 1 61090100017.pdf: 1173276 bytes, checksum: cda7eb208e82169a3eb90adf64163258 (MD5) Previous issue date: 2010-07-07
This thesis aims to evaluate whether humorous television commercials (TVCs) work for non-prescription drugs, known as “over-the-counter” (OTC). The construct humor in advertising is controversial since it involves complex and broad typology, and depends on the audience characteristics. Several studies within different product categories indicated that some consumer goods are better suited for humorous TVCs, while others, such as OTC drugs, may not take advantage from it. Paradoxically, drug announcers spend billions of dollars worldwide in humorous OTC ads. An experiment with real consumers was designed as between-and-within-subjects, to test three hypotheses. Sixty women were exposed to pairs of humorous and non-humorous TVCs, for each of the three drug categories (analgesics, vitamins, and laxatives). We used fictional brand names and real ads, and measured four dependant variables: attitude toward the advertising (AAD), attitude toward the brand (ABR), purchase intention (PI), and brand choice (BC), after subjects being exposed to manipulations of two independent variables: humorous vs. non-humorous TV commercials, for the drug categories. Conditional logit model confirmed that humor does not help to persuade respondents, whose choices, attitudes, and purchase intention were less favorable with humorous TVCs, in comparison to non-humorous executions. Future research is presented regarding marketing for pharmaceutical products.
Pedrouzo, Lanuza Marta. "Pharmaceuticals and personal care products in environmental waters." Doctoral thesis, Universitat Rovira i Virgili, 2010. http://hdl.handle.net/10803/9058.
Повний текст джерелаIn the framework of the present Doctoral Thesis different analytical methods have been developed to determine pharmaceuticals and personal care products (PPCPs) in environmental waters. The term PPCPs cover all the pharmaceuticals, drugs of abuse, hormones, the active compounds included in personal care products, and also metabolites, conjugates and transformation sub-products. The developed methods were based on solid-phase extraction and stir bar sorptive extraction followed by liquid chromatography coupled to mass spectrometry and tandem mass spectrometry. Achieving the low limits of detection, these methods could be applied to the monitoring of these compounds in different sewage treatment plants from Tarragona Region, where not data were available. The PPCPs resulting in the effluent sewage waters can achieve rivers. Therefore, waters from three rivers: Ter, Llobregat and Ebro were analyzed. To complete the study, also drinking water was analyzed to determine PPCPs.
Gibson, Sara Nichols. "Oxidation of pharmaceuticals and personal products by permanganate." Thesis, Georgia Institute of Technology, 2010. http://hdl.handle.net/1853/33870.
Повний текст джерелаКниги з теми "Pharmaceutical producers"
Vaccine nation: A thriller. Las Vegas, NV]: Thomas & Mercer, 2011.
Знайти повний текст джерелаInstitute, Pennsylvania Bar. Pharmaceutical litigation. [Mechanicsburg, Pa.]: Pennsylvania Bar Institute, 2006.
Знайти повний текст джерелаFissore, Davide, Roberto Pisano, and Antonello Barresi, eds. Freeze Drying of Pharmaceutical Products. Boca Raton : CRC Press, [2020] | Series: Advances in drying science and technology: CRC Press, 2019. http://dx.doi.org/10.1201/9780429022074.
Повний текст джерелаCanada. Library of Parliament. Research Branch., ed. Patent protection for pharmaceutical products. [Ottawa]: Library of Parliament, Research Branch, 1994.
Знайти повний текст джерелаAttaway, David H., and Oskar R. Zaborsky, eds. Pharmaceutical and Bioactive Natural Products. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4899-2391-2.
Повний текст джерелаSchaumann, Leif. Pharmaceutical industry perspectives: Japanese pharmaceutical internationalization. Menlo Park, CA (333 Ravenswood Ave., Menlo Park 94025-3493): SRI International, 1990.
Знайти повний текст джерелаBirkinshaw, F. L. Analytical procedures for chiral pharmaceutical products. Manchester: UMIST, 1992.
Знайти повний текст джерелаMerkus, Henk G., Gabriel M. H. Meesters, and Wim Oostra, eds. Particles and Nanoparticles in Pharmaceutical Products. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-94174-5.
Повний текст джерелаPal, Dilipkumar, and Amit Kumar Nayak, eds. Bioactive Natural Products for Pharmaceutical Applications. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54027-2.
Повний текст джерелаCanada, Canada Industry. Chemicals, pharmaceuticals and plastics: Forest products. Ottawa, Ont: Industry Canada, 1995.
Знайти повний текст джерелаЧастини книг з теми "Pharmaceutical producers"
Eggersdorfer, Manfred. "Vitamins — Opportunities and Challenges for Both Western and Chinese Producers." In The Chemical and Pharmaceutical Industry in China, 265–72. Berlin, Heidelberg: Springer Berlin Heidelberg, 2005. http://dx.doi.org/10.1007/3-540-26561-9_21.
Повний текст джерелаRoy, Sudipendra Nath, and Tuhin Sengupta. "Impact of IoT on the Healthcare Producers: Epitomizing Pharmaceutical Drug Discovery Process." In Internet of Things Use Cases for the Healthcare Industry, 127–56. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-37526-3_6.
Повний текст джерелаLancini, Giancarlo, and Arnold L. Demain. "Bacterial Pharmaceutical Products." In The Prokaryotes, 257–80. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-31331-8_28.
Повний текст джерелаDemain, Arnold L., and Giancarlo Lancini. "Bacterial Pharmaceutical Products." In The Prokaryotes, 812–33. New York, NY: Springer New York, 2006. http://dx.doi.org/10.1007/0-387-30741-9_24.
Повний текст джерелаSchaefer, Bernd. "Pharmaceuticals." In Natural Products in the Chemical Industry, 209–518. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54461-3_5.
Повний текст джерелаHoward, John, and Elizabeth E. Hood. "The Future of Plant-Produced Pharmaceuticals and Industrial Proteins." In Commercial Plant-Produced Recombinant Protein Products, 261–74. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43836-7_14.
Повний текст джерелаLipp, Ralph, and Emo Pungor. "Formulation of Biotech Products." In Pharmaceutical Biotechnology, 173–85. Weinheim, FRG: Wiley-VCH Verlag GmbH & Co. KGaA, 2005. http://dx.doi.org/10.1002/3527602410.ch9.
Повний текст джерелаFuchs, Heidi, and Hansjörg Schlegel. "Marketing of Pharmaceutical Products." In Dermatopharmacology of Topical Preparations, 443–54. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-57145-9_26.
Повний текст джерелаRehman, Qudsia, Muhammad Sajid Hamid Akash, Imran Imran, and Kanwal Rehman. "Stability of Pharmaceutical Products." In Drug Stability and Chemical Kinetics, 147–54. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-6426-0_10.
Повний текст джерелаOckerman, Herbert W. "Pharmaceutical and Biological Products." In Inedible Meat by-Products, 283–328. Dordrecht: Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-7933-1_12.
Повний текст джерелаТези доповідей конференцій з теми "Pharmaceutical producers"
Calalb, Tatiana. "MICROALGAE AS BIOTECHNOLOGICAL PRODUCERS OF FOOD, COSMETIC AND PHARMACEUTICAL PRODUCTS." In XIth International Congress of Geneticists and Breeders from the Republic of Moldova. Scientific Association of Geneticists and Breeders of the Republic of Moldova, Institute of Genetics, Physiology and Plant Protection, Moldova State University, 2021. http://dx.doi.org/10.53040/cga11.2021.117.
Повний текст джерелаHada, Izabela Diana. "Analysis and Evolution of Profitability in the Pharmaceutical Field in Romania." In International Conference Innovative Business Management & Global Entrepreneurship. LUMEN Publishing, 2020. http://dx.doi.org/10.18662/lumproc/ibmage2020/55.
Повний текст джерелаBhushan, Indu. "Efficient media for high production of microbial lipase from Bacillus subtilis (BSK-L) using response surface methodology for enantiopure synthesis of drug molecules." In 2nd International Scientific Conference "Plants and Microbes: the Future of Biotechnology". PLAMIC2020 Organizing committee, 2020. http://dx.doi.org/10.28983/plamic2020.044.
Повний текст джерелаArpagaus, Cordin. "Nano spray drying of pharmaceuticals." In 21st International Drying Symposium. Valencia: Universitat Politècnica València, 2018. http://dx.doi.org/10.4995/ids2018.2018.7356.
Повний текст джерелаAhmed S. Hussein, Mai, Mohamed Attia, and Noha Mohamed. "Child-resistant features of pharmaceutical packaging in the egyptian and global market; a comparative study." In 10th International Symposium on Graphic Engineering and Design. University of Novi Sad, Faculty of technical sciences, Department of graphic engineering and design,, 2020. http://dx.doi.org/10.24867/grid-2020-p39.
Повний текст джерелаDeckers, Jan. "Treatment of Low-Level Radioactive Waste by Plasma: A Proven Technology?" In ASME 2010 13th International Conference on Environmental Remediation and Radioactive Waste Management. ASMEDC, 2010. http://dx.doi.org/10.1115/icem2010-40299.
Повний текст джерелаLewis, Neil. "Microspectroscopic imaging of pharmaceutical products." In Biomedical Topical Meeting. Washington, D.C.: OSA, 2004. http://dx.doi.org/10.1364/bio.2004.tha5.
Повний текст джерелаSandhu, Jaspal S., Aman Bhandari, Mahad Ibrahim, and P. Balakrishnan. "Appropriate Design of Medical Technologies for Emerging Regions: The Case of Aurolab." In ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-81291.
Повний текст джерелаKamijo, Koichi. "Future Sales Estimation using Patents." In 9th International Conference on Computational Science and Engineering (CSE 2021). Academy and Industry Research Collaboration Center (AIRCC), 2021. http://dx.doi.org/10.5121/csit.2021.112404.
Повний текст джерелаKesic, Dragan. "Significance of products for pharmaceutical companies." In The 6th International Virtual Scientific Conference. Publishing Society, 2017. http://dx.doi.org/10.18638/ictic.2017.6.1.310.
Повний текст джерелаЗвіти організацій з теми "Pharmaceutical producers"
Seuba, Xavier. Free Trade of Pharmaceutical Products. Geneva, Switzerland: International Centre for Trade and Sustainable Development, 2010. http://dx.doi.org/10.7215/ip_ip_20100426.
Повний текст джерелаLubowa, Nasser, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Pharmaceutical Industry in Uganda: A Review of the Common GMP Non-conformances during Regulatory Inspections. Purdue University, December 2021. http://dx.doi.org/10.5703/1288284317442.
Повний текст джерелаBerndt, Ernst, Zvi Griliches, and Joshua Rosett. Auditing the Producer Price Index: Micro Evidence From Prescription Pharmaceutical Preparations. Cambridge, MA: National Bureau of Economic Research, March 1992. http://dx.doi.org/10.3386/w4009.
Повний текст джерелаHelland, Eric, Darius Lakdawalla, Anup Malani, and Seth Seabury. Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market. Cambridge, MA: National Bureau of Economic Research, March 2014. http://dx.doi.org/10.3386/w20005.
Повний текст джерелаBarefoot, Susan F., Bonita A. Glatz, Nathan Gollop, and Thomas A. Hughes. Bacteriocin Markers for Propionibacteria Gene Transfer Systems. United States Department of Agriculture, June 2000. http://dx.doi.org/10.32747/2000.7573993.bard.
Повний текст джерелаHuber, Sandra, Mikael Remberger, Arntraut Goetsch, Kirsten Davanger, Lennart Kaj, Dorte Herzke, Martin Schlabach, et al. Pharmaceuticals and additives in personal care products as environmental pollutants. Nordic Council of Ministers, August 2013. http://dx.doi.org/10.6027/tn2013-541.
Повний текст джерелаMunhuweyi, Ngonidzashe Portia, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Resource Modelling for the QC Laboratory at XYZ Pharmaceuticals in Southern Africa. Purdue University, November 2021. http://dx.doi.org/10.5703/1288284317431.
Повний текст джерелаBerndt, Ernst, Zvi Griliches, and Joshua Rosett. On the Accuracy of Producer Price Indexes for Pharmaceutical Preparations: An Audit Based on Detailed Firm-Specific Data. Cambridge, MA: National Bureau of Economic Research, October 1990. http://dx.doi.org/10.3386/w3490.
Повний текст джерелаAgu, Monica, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. The Impact of Mentoring as a GMP Capability Building Tool in The Pharmaceutical Manufacturing Industry in Nigeria. Purdue University, December 2012. http://dx.doi.org/10.5703/1288284317447.
Повний текст джерелаDoddridge, Gregory, Steven Doherty, Zhenqi Shi, Ting-Kuo Huang, Nina Cauchon, Tony Wang, Orna Wisniak, Clarice Hutchens, and Isabelle Lequeux. Regulatory submission & lifecycle management strategy of models used in the manufacture of pharmaceutical and biological products. BioPhorum, January 2021. http://dx.doi.org/10.46220/2020reg002.
Повний текст джерела